๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Oncolytic Virus

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors NCT06311578Phase 110 sites๐Ÿ“ New York๐Ÿ“ Philadelphia๐Ÿ“ Pittsburgh Johnson & Johnson Enterprise Innovation Inc. ยท Tests: JNJ-87704916, Cetrelimab, Standard of Care PD(L)-1 H101 Plus TACE for r/m HNSCC NCT07398664Phase 21 site๐Ÿ“ Chengdu West China Hospital ยท Tests: H101, TACE A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors. NCT07185243NA1 site๐Ÿ“ Xiamen Hangzhou Converd Co., Ltd. ยท Tests: recombinant human IL-21-expressing oncolytic vaccinia virus injection PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma NCT07018518Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: PIN +anti-PD1 A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies NCT07231458Phase 15 sites๐Ÿ“ Berlin๐Ÿ“ Tรผbingen๐Ÿ“ Barcelona Abalos Therapeutics GmbH ยท Tests: ABX-001, Pembrolizumab PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor NCT06883149Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: PIN +anti-PD1 GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors NCT06265025Phase 1, Phase 24 sites๐Ÿ“ Goyang-si๐Ÿ“ Seoul๐Ÿ“ Seoul GeneMedicine Co., Ltd. ยท Tests: GM103 (Part A), GM103 (Part B), GM103 and Pembrolizumab (Part C) Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation NCT07076498Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: M032 A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors NCT06368921Phase 13 sites๐Ÿ“ Guangzhou๐Ÿ“ Zhengzhou๐Ÿ“ Jinan Guangzhou Virotech Pharmaceutical Co., Ltd. ยท Tests: VRT106 HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388Phase 13 sites๐Ÿ“ Birmingham๐Ÿ“ St Louis๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: G207 MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors NCT05076760Phase 12 sites๐Ÿ“ Tampa๐Ÿ“ Durham Memgen, Inc. ยท Tests: MEM-288 Intratumoral Injection, Nivolumab, Docetaxel A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors NCT06508307Phase 11 site๐Ÿ“ Zhengzhou GONGCHU Biotechnology Co., Ltd ยท Tests: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patients With Advanced Solid Tumors Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors NCT07001592Phase 11 site๐Ÿ“ Pittsburgh Allegheny Singer Research Institute (also known as Alleghenโ€ฆ ยท Tests: vvDD-hIL-2-RG-1 SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET) NCT06889493Phase 11 site๐Ÿ“ Miami Peter Hosein, MD ยท Tests: Seneca Valley Virus-001 (SVV-001), Nivolumab, Ipilimumab Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC NCT05733598Phase 212 sites๐Ÿ“ Beverly Hills๐Ÿ“ La Jolla๐Ÿ“ Miami Replimune, Inc. ยท Tests: RP2, Bevacizumab, Atezolizumab, Durvalumab, RP2 Monotherapy OH2 Injection in Combination With HX008 for Melanoma. NCT04616443Phase 1, Phase 21 site๐Ÿ“ Beijing Binhui Biopharmaceutical Co., Ltd. ยท Tests: OH2 injection, HX008 injection Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors NCT07424092Phase 22 sites๐Ÿ“ Utrecht๐Ÿ“ Pamplona Clinica Universidad de Navarra, Universidad de Navarra ยท Tests: DNX-2401 Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer NCT07006077Phase 21 site๐Ÿ“ Hangzhou Hangzhou Converd Co., Ltd. ยท Tests: Recombinant human IL-21-expressing oncolytic vaccinia virus injection Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma NCT05717712Phase 11 site๐Ÿ“ Beijing Capital Medical University ยท Tests: Ad-TD-nsIL12 A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced Metastatic Breast Cancer NCT07850869n/a1 site๐Ÿ“ Guangdong Jie Yuan๏ผŒMD A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors NCT06826313Phase 11 site๐Ÿ“ Guangzhou Guangzhou Virotech Pharmaceutical Co., Ltd. ยท Tests: VRT106 A Clinical Study of GO306 in Patients With Advanced Solid Tumors NCT07128914Phase 16 sites๐Ÿ“ Hefei๐Ÿ“ Fuzhou๐Ÿ“ Shenzhen GeneSail Biotech (Shanghai) Co., Ltd. ยท Tests: GO306 Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas NCT05139056Phase 14 sites๐Ÿ“ Duarte๐Ÿ“ Stanford๐Ÿ“ Chicago City of Hope Medical Center ยท Tests: Neural Stem Cells-expressing CRAd-S-pk7, Resection Oncolytic Virus in Esophageal Squamous Cell Carcinoma NCT07061704Phase 1, Phase 21 site๐Ÿ“ Chengdu Sichuan University ยท Tests: Oncolytic Virus: Administered via intratumoral injection (metastatic lesions in the neck or supraclavicular lymph nodesโ€ฆ Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma NCT05717699Phase 11 site๐Ÿ“ Beijing Capital Medical University ยท Tests: Ad-TD-nsIL12 Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors NCT07656116Phase 11 site๐Ÿ“ Langfang Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: VSV injection A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3 NCT06887348n/a2 sites๐Ÿ“ La Jolla๐Ÿ“ Southport Replimune, Inc. ยท Tests: Observational study with no interventions Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients NCT06757153EARLY Phase 11 site๐Ÿ“ Wuhan Zhongnan Hospital ยท Tests: NRG-103 A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas NCT06660056Phase 11 site๐Ÿ“ Beijing GONGCHU Biotechnology Co., Ltd ยท Tests: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Recurrent or Progressโ€ฆ Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) NCT05281471Phase 333 sites๐Ÿ“ Mobile๐Ÿ“ Tucson๐Ÿ“ Duarte Genelux Corporation ยท Tests: olvimulogene nanivacirepvec, Platinum chemotherapy: carboplatin (preferred) or cisplatin, Non-platinum chemotherapy: Phโ€ฆ
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy